Exercise and Soft Tissue Sarcoma

Recruiting now · Not applicable

Conditions studied: Soft Tissue Sarcoma

In brief

The purpose of this study is to evaluate the effect of a neoadjuvant (i.e. pre-treatment) exercise regimen on extremity function and postoperative wound healing. The study group will include patients with a primary diagnosis of soft tissue sarcoma undergoing treatment with neoadjuvant radiation therapy and surgical resection. Patients with upper or lower extremity sarcomas will be considered for enrollment.

Key facts

Study ID

NCT04921917

Run by

Duke University

People needed

24

Starts

2021-04-30

Expected to finish

2030-01-01

Last updated by the study team

2026-04-08

Who can join

Age: 18 and older, up to 85. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males and females within the ages of 18-85
• Diagnosis of soft tissue sarcoma that has been histologically confirmed by an approved reference pathologist
• Sarcoma of the upper or lower extremity location
• Treatment plan that includes neo-adjuvant radiation therapy followed by surgical resection
• Expected primary wound closure performed at the time at surgery
• Any disease stage
• Any tumor grade
• Any histologic subtype
• First or recurrent presentations
• No vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity
• No history of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
• Must be able to comply with follow up visits
• Must be able to provide own consent

You may not qualify if…

• Patients under the age of 18, or over the age of 85
• Treatment plan that does not include neo-adjuvant radiation and surgical excision
• Sarcoma location other than the upper or lower extremity
• History of radiation therapy to the tumor and/or surgical area prior to the current treatment being studied
• High dose steroid therapy (defined as >5mg prednisone, or equivalent, with the last 30 days)
• Active treatment with chemotherapy within the last 30 days
• Inability of the patient to provide informed consent (i.e. dementia, cognitive impairment, non-English speakers)
• Plan for post-operative radiation therapy
• Underlying severe cardiopulmonary disease
• Prior surgery, other than a biopsy, at the site of disease
• Tumors that are ulcerative or fungating through the dermis at the time of presentation
• Vascular invasion or resection/repair/reconstruction that results in decreased perfusion of the extremity
• Vascular disease resulting in clinically apparent compromise in blood flow to the treatment extremity (i.e. peripheral vascular disease with diminished pulses, venous insufficiency with clinical evidence of vascular congestion)
• Actively uncontrolled diabetes mellitus (documentation of history of Diabetes with A1c>8)
• Active deep vein thrombosis in the treatment extremity
• Inability to comply with follow up visits
• Pregnant females (women of childbearing potential must have a negative serum pregnancy test prior to enrollment)

Where it is running

• Duke University — Durham, North Carolina, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.